Clinical trial
A Single-centre, Open-label, Five-way Crossover Study in Healthy Female Participants to Assess the Pharmacokinetics of Nasally Administered Formulations of Teriparatide Compared to a Subcutaneous Injection.
NCT01913834 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-centre, Open-label, Five-way Crossover Study in Healthy Female Participants to Assess the Pharmacokinetics of Nasally Administered Formulations of Teriparatide Compared to a Subcutaneous Injection.
- Lead sponsor
- Nottingham University Hospitals NHS Trust
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- August 31, 2014
- Enrollment
- 7 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.